Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers - Smith, Neil; Blau, Nenad (Molecular genetics and metabolism, 2019)
Gesehen am 04.12.2019